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Background: To address increasing tuberculosis (TB) incidence in foreign-born populations, immigrant TB screening
programs have been implemented in the USA. These programs are modified periodically, the effectiveness of which
have been disputed. The aim of this retrospective study was to assess the value of the 2009 Technical Instructions
for Tuberculosis Screening and Treatment Using Cultures and Directly Observed Therapy (CDOT TB TI) in a cohort of
the USA permanent-resident applicants from China.
Methods: Standardized forms were used to collect demographic, clinical, and laboratory data of Chinese individuals
screened at the Guangdong International Travel Healthcare Center for permanent residence in the USA between
October 08, 2009 and December 31, 2012. Applicants’ data were further retrospectively evaluated by three
experienced panel physicians and radiologists according to the 1991 Technical Instructions for Tuberculosis
Screening and Treatment (TI). TB cases and characteristics identified by the 1991 and expanded 2009 programs
were compared.
Results: The CDOT TB TI identified more than twice as many TB cases that required treatment completion before
clearance for travel than the 1991 TI (270 vs. 131). In addition, the expanded screening program identified more cases
of negative sputum smear but positive culture (181 vs. 44), and more cases of radiography suggestive of inactive
(22 vs. 3) and active (248 vs. 128) TB. Specifically, the 1991 TI screening program failed to identify 25/38 (65.79%) cases
carrying drug-resistant isolates, and 13/131 (9.92%) would have been inappropriately treated. Moreover, 220/270
(81.48%) of the cases were asymptomatic, which were identified by screening and subsequently treated. Improved
chest radiograph and sputum negative conversion occurred in all treated cases.
Conclusion: CDOT TB TI, a screening program that includes sputum culture and drug susceptibility tests, identifies a
greater number of TB cases, likely contributing to the overall decrease in TB prevalence in host (USA) and origin (China)
countries.
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For industrialized countries with a low burden of tubercu-
losis (TB), the incidence of the disease is primarily attrib-
uted to foreign-born individuals originating from high-TB
burden countries [1-8]. To combat this, programs for TB
screening among immigrants have been instituted and
evaluated [9,10]. Typically, screening involves chest radio-
graph (CXR) alone or with clinical examination, though* Correspondence: samzjxc@163.com
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these programs vary with regard to national legislation, re-
source availability, and public health risk management
practices [1,11-13], and their coverage and effectiveness
remain disputable [14,15].
As the country with the largest number of international
migrants, the percentage of emigrant TB cases in the USA
has increased substantially since the Centers for Disease
Control and Prevention (CDC) began collecting data on
place of birth in 1986 [16-19]. During this time, technical
instruction and guidance for TB screening has periodically
been modified [11,20,21]. Beginning in 1991, the CDChis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Treatment (TI) required that individuals overseas applying
for permanent residence in the USA undergo TB screening.
For those suspected of having active pulmonary TB, labora-
tory investigation was required, but not sputum culture or
drug susceptibility testing (DST) [18,21-23]. In 2007, these
requirements were expanded to include sputum cultures
for applicants with signs or symptoms of TB, an abnormal
CXR suggestive of TB disease, or human immunodeficiency
virus (HIV) infection. The updated version in 2009 was
named as the TI Using Cultures and Directly Observed
Therapy (CDOT TB TI). Additional revisions incorporated
DST for positive cultures to guide treatment and a shorter
validity period for travel clearance [22,23]. As a result, the
expanded overseas screening protocol reduced the import-
ation of active TB disease from Mexico, the Philippines,
and Vietnam [20], resulting in an annual savings of $15 mil-
lion [24]. However, data from the countries of origin are
needed to obtain definitive conclusions concerning the ef-
fect of CDOT TB TI on reduced importation of TB.
China has become the 4th largest source of migrants
in the world [25]. China is also ranked 4th of the top 5
source countries of TB-infected emigrants to the USA,
and a large number of USA-bound immigrants with sus-
pected TB are identified in overseas screening [19,20].
Although the expanded screening program was imple-
mented in China in 2009, there are no current reports
evaluating the effects of CDOT TB TI on TB epidemi-
ology in USA-bound migrants or within China or other
countries of origin. Therefore, we studied TB cases
among applicants for permanent USA residence at the
largest assigned panel site in China, the Guangdong
International Travel Healthcare Center (GDITHC) of
Guangdong Province. Specifically, we aimed to evaluate
the effectiveness of the CDOT TB TI and identify factors
that may aid other emigration and immigration coun-
tries with respect to TB incidence.
Methods
Study design and applicants
A retrospective study was conducted to assess the effect-
iveness of the expanded screening program (CDOT TB
TI) on individuals applying for permanent USA residence
at GDITHC between October 08, 2009 and December 31,
2012. In accordance with the CDOT TB TI, Chinese ap-
plicants ≥15 years of age require a medical history, phys-
ical examination and CXR; applicants 2–15 years of age
require a medical history, physical examination and tuber-
culin skin test or interferon-gamma release assay and
should undergo CXR evaluation if a tuberculin skin test ≥
10 mm or interferon-gamma release assay is positive. Ap-
plicants with signs or symptoms of TB disease, an abnor-
mal CXR suggestive of TB disease, or HIV infection are
required to provide three consecutive morning sputumspecimens. Sputum tests include a smear for acid-fast ba-
cilli (AFB) and culture for Mycobacterium tuberculosis
(MTB).
Applicants’ data were further retrospectively evaluated
according to the 1991 TI for comparison. For these evalu-
ations, three experienced panel physicians and radiologists
were invited to review related CXRs and other clinical
characteristics, and to provide a unanimous final decision.
Applicants with infectious pulmonary TB disease, includ-
ing laryngeal and pleural TB, must undergo directly ob-
served therapy at a CDC Division of Global Migration and
Quarantine (DGMQ)-approved treatment site before travel
is allowed. For those treated at non-DGMQ-approved sites,
the evaluation must be repeated one year after completion
of treatment prior to travel clearance. All treatment regi-
mens are required to follow guidelines of the current
American Thoracic Society/CDC/Infectious Diseases Soci-
ety of America, which incorporate DST results.
Data collection
Standardized forms were used to collect applicants’ demo-
graphic, clinical, and laboratory data from the working
and surveillance database of GDITHC, including: date of
birth, sex, medical history (including prior history of TB
disease and treatment), physical examination findings, TB
exposure, current TB symptoms and signs, HIV-test re-
sults, CXR findings, AFB sputum smear and MTB culture
results, and treatment course and outcomes (up until
March 31, 2014). To compare epidemiologic characteris-
tics of TB among the applicants, Guangdong Province,
and China as a whole, epidemiologic data were cited from
two published articles describing the results of the Fifth
National Survey on TB Disease conducted in 2010 [26,27].
Statistical analysis
All analyses were performed using SPSS 14.0 software
(SPSS Inc., Chicago, IL, USA). A χ2 or Fisher’s exact test
was used to compare proportions. Two-tailed P < 0.05
was considered as statistically significant.
Ethical review
This study was exempt from approval by the GDITHC
Review Board as it analyzed working and surveillance
data that is routinely collected, and applicant-identifying
information was removed.
Results
In total, 83,214 applicants for USA permanent residence
underwent overseas TB screening at GDITHC during the
study period; the male to female ratio was 1.87/1 and mean
age was 39 y (range: 3 mo to 87 y). Approximately half of
the applicants came from Guangdong Province where the
panel site is located. A summary of the applicant screening
process is presented in Figure 1. Of the 3,276 applicants
Medical history 
Physical examination 
Positive tuberculin skin test or 
IGRA (if 2–14 years of age) 
Chest radiograph 
Three sputum specimens for AFB smear and MTB culture 
(n = 3212) 
Clinical PTB though 
sputum culture negative 
(n = 48) 
≥ 1 positive sputum 
culture 
(n = 222) 
All sputum smears and cultures 
negative with no signs of active PTB 
(n = 2942) 
Drug susceptibility tests on positive cultures and treatment 
completed prior to travel clearance 
(n = 270) 
Cleared for travel with PTB suspect 
classification 
(n = 2942) 
Figure 1 Summary of overseas tuberculosis screening algorithm based on the Technical Instructions for Tuberculosis Screening and
Treatment Using Cultures and Directly Observed Therapy. AFB = acid-fast bacilli, IGRA = interferon-gamma release assays, MTB =Mycobacterium
tuberculosis, PTB = pulmonary tuberculosis, TB = tuberculosis.
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or inactive, and one with a positive HIV status, 3,212 com-
pleted the screening procedures; 65 applicants failed to pro-
vide the required sputum specimens. Screening results
indicated that 270 cases were required to complete TB
treatment before clearance for travel was provided, for a TB
rate of 0.32% (270/83,214).
Characteristics of the identified TB cases are presented
in Table 1. Similar to the findings in Guangdong Province
[26,27], 58.52% (158/270) of the TB cases were among in-
dividuals 35–64 years of age. Twelve applicants had been
diagnosed with active pulmonary TB by the National Tu-
berculosis Control Program (NTP) as they reported symp-
toms of chronic cough (cough ≥ 2 wk), bloody sputum, or
chest pain, and were still taking TB medicines at the time
of screening, whose sputum tests came back as negative
for both smear and culture. A total of 38 applicants failed
to get treatment for chronic cough, fatigue, and low fever
before screening, from whom 35 MTB isolates were
detected and three sputum tests came back as negative for
both smear and culture. A large majority (81.48%; 220/
270) of the identified cases had no current TB symptoms
or treatment, with or without history of previous TB dis-
ease/treatment, much higher than in National survey
(43.1%) [27]; 187 of these 220 individuals were MTB-
culture positive, 6 were nontuberculous mycobacteria (five
with positive-AFB smear), 10 were negative for culture but
had positive-AFB smears, and the remaining 17 were
negative for smear and culture. All 20 of the individualswith negative smears and cultures (three reporting current
TB symptoms without treatment and 17 without symp-
toms or treatment) were clinically diagnosed with smear-
negative pulmonary TB, which was consistent with the
definition in the International Standards for Tuberculosis
Care of the World Health Organization: positive tubercu-
lin skin test or interferon-gamma release assays, chest
radiography suggestive of active TB, no improvement
in response to a course of broad-spectrum antibiotics
(excluding anti-TB drugs, fluoroquinolones, and amino-
glycosides), but improvement in response to 1–2 months
of a standard anti-TB regimen consisting of isoniazid, ri-
fampicin, pyrazinamide and ethambutol. According to the
CDOT TB TI, the clinically diagnosed smear-negative
cases and those with positive-AFB smear and nontubercu-
lous mycobacteria were all required to complete TB treat-
ment before clearance for travel. Among the 32 cases with
negative sputum smears and cultures, 12 (37.6%) were
currently on TB medications, and 20 (62.5%) were re-
quired to complete TB treatment due to clinical diagnosis
of smear-negative pulmonary TB. The rate of positive AFB
smears among applicants (0.06%) was not different from
that of Guangdong Province (0.04%) or the National Sur-
vey on TB Disease (0.07%), whereas the rate of bacterial-
positive pulmonary TB was significantly higher (0.27 vs.
0.06 and 0.14%, respectively; Ps < 0.05) [26,27]. Among the
222 MTB isolates, 17.12% (38/222) showed first-line drug
resistance and 2.25% (5/222) were multidrug resistant
(MDR), most commonly to isoniazid and streptomycin,
Table 1 Characteristics of TB cases identified under different technical instruction
Characteristics CDOT TB TI (n) 1991 TI (n)
TB cases identified 270 131










TB now, on treatment 12 12
TB previous, treated 33 20
TB previous, untreated 8 0
TB previous suspect classification, untreated 5 2
Current TB symptoms 40§ 19
Chest radiograph characteristics
Consistent with inactive TB 22 3
Consistent with active TB 248 128
Sputum test
Positive AFB smear and MTB culture 41 40
Positive AFB smear and negative MTB culture 10 10
Negative AFB smear and positive MTB culture 181 44
Negative AFB smear and negative MTB culture 32 31
Nontuberculous mycobacteria 6* 6
Drug susceptibility test for MTB isolates
Total isolates 222 84
Pan-susceptible to first-line anti-TB drugs 184 71
First-line primary-drug resistant 33 11
First-line acquired-drug resistant 5 2
Multidrug resistant 5¶ 2
Abbreviations: AFB = acid fast bacilli, CDOT TB TI Technical Instructions for Tuberculosis Screening and Treatment Using Cultures and Directly Observed Therapy
(2009), MTB =Mycobacterium tuberculosis, TB = tuberculosis, 1991 TI = Technical Instructions for Tuberculosis Screening and Treatment (1991).
Notes: §two persons were currently on treatment; *one with negative AFB smear, ¶four cases of primary and one case of acquired multidrug resistance.
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were detected in 16.67% (33/198) of applicants, which is
similar to the 18.4% reported in Guangdong Province
[26,27].
All the applicants’ data were further retrospectively
reviewed according to the 1991 TI protocol, for which
248/83,214 applicants would have been required to submit
sputum specimens based on CXR suggestive of active pul-
monary TB (Figure 2). Of these, 55 applicants would have
been identified with infectious active pulmonary TB (due
to ≥ 1 positive sputum smear), and an additional 73 appli-
cants would not have been cleared for travel because ofclinical diagnosis warranting treatment for pulmonary TB
regardless of laboratory results; 9/73 had been on TB
medications at the time of screening and 64/73 would
have been diagnosed as smear-negative pulmonary TB.
Actually, 44 of the 64 individuals that were negative for
smear were positive for MTB when culture testing was
performed. The 1991 TI would have also required three
cases with CXR suggestive of inactive TB but still on TB
medications to complete treatment before travel clearance
would be granted. Thus, only 0.16% (131/83,214) of appli-
cants would have been retained from clearance for travel,
a rate that is roughly half of the result based on the CDOT
Chest radiograph (all applicants ≥15 y of age, or those 2–14 y of age with TB symptoms or signs) 
Inactive TB 
(n = 2964) 
Active TB 
(n = 248) 
Three sputum specimens for acid-fast bacilli smear 
≥ 1 positive 
sputum smear 
(n = 55) 
Clinical PTB, though sputum smear 
negative 
(n = 73, including 9 on treatment) 
On TB 
treatment 
(n = 3) 
Treatment completion needed before travel 




travel with TB 
suspect 
classification 





(n = 2961) 
Figure 2 Summary of overseas tuberculosis screening algorithm based on the Technical Instruction for Tuberculosis Screening and
Treatment (1991). PTB = pulmonary tuberculosis, TB = tuberculosis.
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nearly half of the applicants with CXR suggestive of active
TB would not have been restricted from travel due to
negative AFB smears. Furthermore, a significantly smaller
proportion of applicants with CXR suggestive of inactive
TB would have been detected (2.3 vs. 8.1% by CDOT TB
TI; P < 0.05). Moreover, approximately two-thirds of the
cases carrying drug-resistant isolates would have been
missed based on the 1991 TI, including three MDR-TB
cases. Among the 131 cases required to complete TB
treatment, 9.92% (13/131) carrying drug-resistant isolates
would most likely have been treated with a six-month
standard TB regimen, which most likely would have failed
due to lack of DST, including two MDR-TB cases.
Of the identified applicants, 227 completed their TB treat-
ment, which lasted 6–12 mo (24 mo for the two MDR-TB
cases). Culture negative conversion within 60 d was slightly
higher for applicants treated at the DGMQ-approved sites
compared with non-approved sites (97.5 vs. 94.5%). Two
MDR-TB cases completed their directly observed therapy
consisting of second-line drugs at GDITHC, while the other
three cases were lost. After completion of treatment, CXRrevealed improvements in lung lesions in 227 applicants, in-
cluding the 22 cases with initial CXR findings suggestive of
inactive TB. Only one case relapsed during the study period,
involving an applicant who had completed a treatment
course at a non-approved treatment site, and had been wait-
ing for another year. Eight applicants were unable to emi-
grate to the USA after completing treatment as the validity
period for travel clearance was too short (3 mo), despite the
absence of positive culture conversion.
Discussion
Previous studies have indicated that the inclusion of the
MTB culture would identify an additional 250 TB cases
per year in foreign-born individuals screened prior to USA
entry [21,28]. In fact, the number of positive-culture TB
cases detected among recent USA immigrant arrivals has
dramatically decreased after implementing the expanded
screening protocol [20]. Consistent with this, the results of
this study indicate the expanded overseas screening pro-
gram prevented the emigration of more than double the
TB cases from China, primarily from cases with negative
AFB smears. Although such cases are less infectious, the
Liang et al. BMC Public Health  (2015) 15:231 Page 6 of 8prevalence of negative-smear TB cases among immigrants
and refugees highlights the necessity for effective screen-
ing and management to protect public health [29].
The highest rates of TB cases occur near to the time
of entering among foreign-born individuals in the USA
[28], similar to other countries with a low TB epidemi-
ology [30]. Although the TB incidence typically drops
among these immigrants after one or two years, foreign-
born individuals are still more likely develop TB disease
than native-born individuals, even after 20 years
[28,31,32]. This is attributed to latent TB infection
(LTBI), which presents an important and cost-effective
opportunity for eliminating TB in host countries [5,6,8].
However, these studies may have included individuals
who were considered free of active TB, or even had CXR
suggestive of active TB, but may have had positive cul-
tures if sputum tests were conducted. These cases then
enter the host country with a TB suspect classification,
which can be considered as LTBI, and would thus be di-
agnosed during subsequent domestic follow-ups. Be-
tween 63.6% and < 100% of these immigrants completed
follow-up evaluations [29], as it is voluntary for individ-
uals with suspect TB classification to visit a health de-
partment after entering the USA [18], and detection of
missed cases is prolonged after arrival. This may contrib-
ute to the high TB incidence within the foreign-born
population, even decades after entry.
The use of CXR-based TB screening protocols in
foreign-born populations has been disputed in many
countries [33-35]. In CDOT TB TI, CXR screening further
evaluates cases with results indicating inactive pulmonary
TB. The CDOT TB TI also stipulates that a greater num-
ber of these applicants undergo an MTB test (e.g. 3,212 vs.
248 with 1991 TI based on our findings). Moreover, inclu-
sion of the sputum culture in the expanded TB screening
program doubled the number of active TB cases that re-
quired completion of treatment before being allowed to
emigrate from China to the USA.
More asymptomatic TB cases were detected at
GDITHC than reported in the National Survey in 2010
[26,27]. An explanation for this is that immigration
health screening represents an active case-finding
method and identifies cases at an earlier stage of dis-
ease. Consequently, immediate treatment of these cases
prevents the transmission of MTB within the surround-
ing population. The expanded CDOT TB TI provided
early diagnosis and treatment for 258 applicants in this
study. Importantly, 85.0% of the asymptomatic TB cases
in this study were confirmed by bacterial culture,
highlighting the value of the sputum test. In China and
many developing countries, there is an insufficient
number of capacity-qualified labs [36]. Thus, panel sites
that follow the CDOT TB TI and qualify for smear mi-
croscopy and culture and DST capacity can benefit theNTP of countries of origin by identifying and treating
more cases [24].
Many of the TB applicants in this study ignored TB
symptoms, similar to findings in the National Survey in
China in 2000 and 2010 [26,37]. The mildness of the
symptoms, along with insufficient knowledge and atti-
tude concerning TB, likely contributed to the failure to
seek treatment. Once arriving in the host country, un-
familiarity with the healthcare system and fear of being
repatriated can further delay medical evaluation [38].
Therefore, health screening of permanent residence ap-
plicants provides an opportunity for education and pro-
motion of healthcare-related topics [9,13].
Several studies have questioned the quality of work
performed at panel sites [11,18,21,39] despite the docu-
mented value of overseas screening [29,40]. The 0.3% TB
detection rate at GDITHC was similar with other studies
[11,13], though much lower than that in Vietnam (9.4%)
[21]. Indeed, the prevalence of TB has remarkably de-
clined in China in recent years, only 459/100,000 in 2010
and 230/100,000 in Guangdong Province [26,27], largely
because of a great effort from the NTP [36]. A large propor-
tion of applicants from our study were from Guangdong
Province, thus, the 0.3% TB detection rate at GDITHC is
reasonable and consistent with that of Guangdong Province
and lower than national data. The age distribution and pro-
portion of primary drug-resistant isolates of this study co-
hort were also similar to the survey in Guangdong.
The obvious disadvantage of the CDOT TB TI is that
many applicants with CXR findings consistent with “old
healed TB,” including those who do not need further
treatment, are required to undergo a sputum test before
being cleared for travel. This requirement imposes a
lengthy delay, as results of sputum cultures can take
42 days, compared to obtaining results from the sputum
smear test in one day. However, information related to
prolonged wait times or the additional expense is not
routinely collected during pre-visa medical evaluations.
Extensive study should be carried out on this important
topic of cost-effectiveness of the expanded overseas TB
screening policy.
There are a few limitations of this study worth men-
tioning. First, the study cohort was entirely comprised of
applicants at the GDITHC, one of the panel sites in
China; thus, selection bias may play a role in this study.
Second, due to lack of follow-up data of the studied
group of applicants after arriving in the USA, the long-
term implications of TB prevalence in the USA cannot
be determined.
Conclusion
Compared to the 1991 TI, the CDOT TB TI identified a
larger number of TB cases that require treatment prior
to emigration, including asymptomatic cases and cases
Liang et al. BMC Public Health  (2015) 15:231 Page 7 of 8missed by the NTP. The inclusion of MTB cultures played a
key role in finding cases that can be considered LTBI, which
will likely impact results from domestic follow-ups. Overseas
panel sites following CDOT TB TI can identify and treat
more asymptomatic cases, serving as a useful supplement to
the NTP. As global investment is the ideal long-term TB
control strategy [24,41], programs such as the CDOT TB TI
represent a viable, effective management system, as evi-
denced by the reduced prevalence of TB in China.
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